Titre : Polyribosomes

Polyribosomes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Management
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Polyribosomes : Questions médicales les plus fréquentes", "headline": "Polyribosomes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Polyribosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-06", "dateModified": "2025-05-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Polyribosomes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Ribosomes", "url": "https://questionsmedicales.fr/mesh/D012270", "about": { "@type": "MedicalCondition", "name": "Ribosomes", "code": { "@type": "MedicalCode", "code": "D012270", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.430.214.190.875.811" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Réticulum endoplasmique rugueux", "alternateName": "Endoplasmic Reticulum, Rough", "url": "https://questionsmedicales.fr/mesh/D018870", "about": { "@type": "MedicalCondition", "name": "Réticulum endoplasmique rugueux", "code": { "@type": "MedicalCode", "code": "D018870", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.430.214.190.875.811.740.300" } } } ], "about": { "@type": "MedicalCondition", "name": "Polyribosomes", "alternateName": "Polyribosomes", "code": { "@type": "MedicalCode", "code": "D011132", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Timur N Baymukhametov", "url": "https://questionsmedicales.fr/author/Timur%20N%20Baymukhametov", "affiliation": { "@type": "Organization", "name": "Structural biology department, National Research Center 'Kurchatov Institute', Moscow 123182, Russia." } }, { "@type": "Person", "name": "Dmitry N Lyabin", "url": "https://questionsmedicales.fr/author/Dmitry%20N%20Lyabin", "affiliation": { "@type": "Organization", "name": "Institute of Protein Research RAS, Pushchino, Moscow Region 142290, Russia." } }, { "@type": "Person", "name": "Yury M Chesnokov", "url": "https://questionsmedicales.fr/author/Yury%20M%20Chesnokov", "affiliation": { "@type": "Organization", "name": "Probe and Electron Microscopy Resource Center, National Research Center 'Kurchatov Institute', Moscow 123182, Russia." } }, { "@type": "Person", "name": "Ivan I Sorokin", "url": "https://questionsmedicales.fr/author/Ivan%20I%20Sorokin", "affiliation": { "@type": "Organization", "name": "Institute of Protein Research RAS, Pushchino, Moscow Region 142290, Russia." } }, { "@type": "Person", "name": "Evgeniya V Pechnikova", "url": "https://questionsmedicales.fr/author/Evgeniya%20V%20Pechnikova", "affiliation": { "@type": "Organization", "name": "Probe and Electron Microscopy Resource Center, National Research Center 'Kurchatov Institute', Moscow 123182, Russia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Position paper on management of personal data in environment and health research in Europe.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35696847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.envint.2022.107334" } }, { "@type": "ScholarlyArticle", "name": "Construction of Economic Data Management System Based on BP Neural Network.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35845916", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/9036917" } }, { "@type": "ScholarlyArticle", "name": "Discuss the Application of Data Services in Data Health Management of High-Risk Pregnant and Lying-In Women in Smart Medical Care.", "datePublished": "2022-08-25", "url": "https://questionsmedicales.fr/article/36082174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/5957697" } }, { "@type": "ScholarlyArticle", "name": "Data management plans as linked open data: exploiting ARGOS FAIR and machine actionable outputs in the OpenAIRE research graph.", "datePublished": "2023-11-02", "url": "https://questionsmedicales.fr/article/37919767", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13326-023-00297-5" } }, { "@type": "ScholarlyArticle", "name": "Ten simple rules for maximizing the recommendations of the NIH data management and sharing plan.", "datePublished": "2022-08-03", "url": "https://questionsmedicales.fr/article/35921268", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pcbi.1010397" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Structures cellulaires", "item": "https://questionsmedicales.fr/mesh/D022082" }, { "@type": "ListItem", "position": 4, "name": "Espace intracellulaire", "item": "https://questionsmedicales.fr/mesh/D042541" }, { "@type": "ListItem", "position": 5, "name": "Cytoplasme", "item": "https://questionsmedicales.fr/mesh/D003593" }, { "@type": "ListItem", "position": 6, "name": "Structures cytoplasmiques", "item": "https://questionsmedicales.fr/mesh/D022083" }, { "@type": "ListItem", "position": 7, "name": "Organites", "item": "https://questionsmedicales.fr/mesh/D015388" }, { "@type": "ListItem", "position": 8, "name": "Ribosomes", "item": "https://questionsmedicales.fr/mesh/D012270" }, { "@type": "ListItem", "position": 9, "name": "Polyribosomes", "item": "https://questionsmedicales.fr/mesh/D011132" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Polyribosomes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Polyribosomes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Polyribosomes", "description": "Comment détecte-t-on les polyribosomes ?\nQuels tests sont utilisés pour étudier les polyribosomes ?\nLes polyribosomes sont-ils visibles en microscopie optique ?\nPeut-on quantifier les polyribosomes ?\nLes polyribosomes sont-ils liés à des maladies ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Polyribosomes", "description": "Quels symptômes sont liés aux dysfonctionnements des polyribosomes ?\nLes polyribosomes affectent-ils la croissance cellulaire ?\nY a-t-il des symptômes neurologiques associés ?\nLes polyribosomes influencent-ils le métabolisme ?\nPeut-on observer des symptômes immunitaires ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Polyribosomes", "description": "Comment prévenir les dysfonctionnements des polyribosomes ?\nLes vaccinations influencent-elles les polyribosomes ?\nY a-t-il des facteurs environnementaux à surveiller ?\nL'exercice physique a-t-il un impact ?\nDes contrôles médicaux réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Polyribosomes", "description": "Comment traiter les dysfonctionnements des polyribosomes ?\nDes médicaments peuvent-ils affecter les polyribosomes ?\nY a-t-il des approches nutritionnelles ?\nLes thérapies géniques peuvent-elles aider ?\nDes traitements expérimentaux existent-ils ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Polyribosomes", "description": "Quelles complications peuvent survenir avec des polyribosomes défectueux ?\nLes polyribosomes affectent-ils le cancer ?\nY a-t-il des risques de maladies neurodégénératives ?\nLes infections peuvent-elles aggraver les problèmes de polyribosomes ?\nDes troubles de croissance peuvent-ils survenir ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Polyribosomes", "description": "Quels facteurs génétiques influencent les polyribosomes ?\nL'alimentation joue-t-elle un rôle ?\nLe stress oxydatif impacte-t-il les polyribosomes ?\nLes toxines environnementales sont-elles un risque ?\nLe vieillissement affecte-t-il les polyribosomes ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les polyribosomes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les polyribosomes sont généralement observés par microscopie électronique." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les polyribosomes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse par centrifugation et l'électrophorèse sur gel sont courantes." } }, { "@type": "Question", "name": "Les polyribosomes sont-ils visibles en microscopie optique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils nécessitent une microscopie électronique pour être visualisés." } }, { "@type": "Question", "name": "Peut-on quantifier les polyribosomes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par des méthodes comme la spectrophotométrie et l'analyse d'images." } }, { "@type": "Question", "name": "Les polyribosomes sont-ils liés à des maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur formation peuvent être associées à certaines pathologies." } }, { "@type": "Question", "name": "Quels symptômes sont liés aux dysfonctionnements des polyribosomes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la synthèse protéique peuvent entraîner des symptômes variés." } }, { "@type": "Question", "name": "Les polyribosomes affectent-ils la croissance cellulaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une synthèse protéique altérée peut inhiber la croissance cellulaire." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles neurologiques peuvent survenir si la synthèse protéique est affectée." } }, { "@type": "Question", "name": "Les polyribosomes influencent-ils le métabolisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle clé dans le métabolisme cellulaire par la synthèse des protéines." } }, { "@type": "Question", "name": "Peut-on observer des symptômes immunitaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans les polyribosomes peuvent affecter la réponse immunitaire." } }, { "@type": "Question", "name": "Comment prévenir les dysfonctionnements des polyribosomes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces dysfonctionnements." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les polyribosomes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent améliorer la réponse immunitaire et la fonction des polyribosomes." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à surveiller ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut affecter la fonction des polyribosomes." } }, { "@type": "Question", "name": "L'exercice physique a-t-il un impact ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé cellulaire et la fonction des polyribosomes." } }, { "@type": "Question", "name": "Des contrôles médicaux réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans de santé réguliers peuvent aider à détecter des anomalies précocement." } }, { "@type": "Question", "name": "Comment traiter les dysfonctionnements des polyribosomes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente, souvent par des thérapies ciblées." } }, { "@type": "Question", "name": "Des médicaments peuvent-ils affecter les polyribosomes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent moduler la synthèse protéique via les polyribosomes." } }, { "@type": "Question", "name": "Y a-t-il des approches nutritionnelles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une nutrition adéquate peut soutenir la synthèse protéique et la fonction des polyribosomes." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent corriger des défauts génétiques affectant les polyribosomes." } }, { "@type": "Question", "name": "Des traitements expérimentaux existent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur des traitements ciblant les polyribosomes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des polyribosomes défectueux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles métaboliques et des maladies dégénératives peuvent survenir." } }, { "@type": "Question", "name": "Les polyribosomes affectent-ils le cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur fonction peuvent contribuer à la progression du cancer." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies neurodégénératives ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements des polyribosomes sont liés à des maladies comme Alzheimer." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver les problèmes de polyribosomes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent perturber la synthèse protéique via les polyribosomes." } }, { "@type": "Question", "name": "Des troubles de croissance peuvent-ils survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans les polyribosomes peuvent entraîner des retards de croissance." } }, { "@type": "Question", "name": "Quels facteurs génétiques influencent les polyribosomes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des mutations génétiques peuvent affecter la formation et la fonction des polyribosomes." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence en nutriments essentiels peut perturber la fonction des polyribosomes." } }, { "@type": "Question", "name": "Le stress oxydatif impacte-t-il les polyribosomes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut endommager les ribosomes et affecter leur fonction." } }, { "@type": "Question", "name": "Les toxines environnementales sont-elles un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut nuire à la synthèse protéique via les polyribosomes." } }, { "@type": "Question", "name": "Le vieillissement affecte-t-il les polyribosomes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut entraîner une diminution de l'efficacité des polyribosomes." } } ] } ] }

Sources (10000 au total)

Discuss the Application of Data Services in Data Health Management of High-Risk Pregnant and Lying-In Women in Smart Medical Care.

In order to improve the refined management of hospitals, promote the scientific development of smart hospitals in medical institutions, and solve the problem of data filling and reporting that is incr... A total of 84 high-risk pregnant women admitted to our hospital from January 2020 to October 2021 were selected and screened for high-risk pregnant women. Risk pregnant women were divided into a routi... After the intervention, the activities of daily living, follow-up, fetal monitoring, and self-protection behaviors in the DS medical group were higher than those in the routine intervention group, and... The application of data services in a smart medical high-risk maternity-related data management platform enables the promotion of high-risk pregnant women's self-care behaviors and improves negative e...

Data management plans as linked open data: exploiting ARGOS FAIR and machine actionable outputs in the OpenAIRE research graph.

Open Science Graphs (OSGs) are scientific knowledge graphs representing different entities of the research lifecycle (e.g. projects, people, research outcomes, institutions) and the relationships amon... A comparative analysis was conducted between the data models of ARGOS and OpenAIRE Research Graph against the DMP Common Standard. Following this, we extended ARGOS with export format converters and s... This paper, to our knowledge, is the first to introduce exposing ma-DMPs in OSGs and making the link between OSGs and DMPs, introducing the latter as entities in the research lifecycle. Further, it pr...

Data management system for diabetes clinical trials: a pre-post evaluation study.

Data management system for diabetes clinical trials is used to support clinical data management processes. The purpose of this study was to evaluate the quality and usability of this system from the u... This study was conducted in 2020, and the pre-post evaluation method was used to examine the quality and usability of the designed system. Initially, a questionnaire was designed and distributed among... There was no statistically significant differences between the users' perspectives about the information quality, service quality, achievements, and communication before and after using the system. Ho... It seems that the designed system largely met the users' expectations in most areas. However, the system quality and users' autonomy need further attentions. In addition, the system should be used in ...